FRESENIUS MEDICAL CARE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.77 EUR | -0.05% |
|
+3.06% | -0.58% |
| 09:02am | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies | ZD |
| Apr. 24 | European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading | MT |
Presenter SpeechRobert Powell (Executives)Hello, everyone. Good morning, good afternoon or goo...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-06
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
37.79
EUR
Average target price
39.01
EUR
Spread / Average Target
+3.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.58% | 11.88B | |
| -14.73% | 84.87B | |
| +16.05% | 83.08B | |
| +10.92% | 29.4B | |
| -12.73% | 16.72B | |
| -3.63% | 16.4B | |
| -1.78% | 15.04B | |
| -31.75% | 11.86B | |
| -4.71% | 11.88B | |
| +26.74% | 11.64B |
- Stock Market
- Equities
- FME Stock
- News Fresenius Medical Care AG
- Transcript : Fresenius Medical Care AG & Co. KGaA - Analyst/Investor Day
